Target intelligence / Profile preview

Plasmodium falciparum heme polymerization process

Molecular classification
Other
01

Overview

The Plasmodium falciparum heme polymerization process is a critical detoxification mechanism employed by the malaria parasite during its intraerythrocytic developmental stage (Sullivan, 2002). As the parasite degrades host hemoglobin to acquire essential amino acids, it releases large quantities of free heme (ferriprotoporphyrin IX), which is highly toxic due to its ability to generate reactive oxygen species and destabilize cellular membranes (Hempelmann, 2007). To survive, the parasite converts this toxic heme into an insoluble, chemically inert crystalline pigment called hemozoin (Egan, 2008). This process takes place within the parasite's acidic digestive vacuole and is the primary target for several classes of antimalarial drugs, most notably the 4-aminoquinolines and quinoline methanols (Weissbuch & Leiserowitz, 2008). Drugs like chloroquine interfere with this pathway by forming complexes with heme or capping the growing hemozoin crystals, thereby preventing further polymerization and causing the accumulation of toxic heme, which ultimately leads to parasite death (Fidock et al., 2000). However, the clinical utility of targeting this process is increasingly threatened by the widespread development of resistance, often mediated by mutations in the PfCRT transporter (Wellems & Plowe, 2001).

Other names
Heme detoxification pathwayHemozoin formationβ-hematin crystallizationFerriprotoporphyrin IX detoxification
02

Mechanism of action

Inhibition of the biocrystallization of toxic free heme into inert hemozoin, leading to the accumulation of ferriprotoporphyrin IX which causes oxidative damage and parasite death (Egan, 2008; Weissbuch & Leiserowitz, 2008).

03

Biological functions

Other
04

Disease associations

Infection
05

Safety considerations

Drug resistance (PfCRT-mediated)Retinal toxicityCardiovascular effects (QT prolongation)Neuropsychiatric side effects
06

Interacting drugs

Chloroquine

7 more in the full profile.

07

Biomarkers

Hemozoin levelsParasitemiaPfCRT K76T mutationPfMDR1 polymorphisms

Beyond the preview

Go deeper on Plasmodium falciparum heme polymerization process.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Plasmodium falciparum heme polymerization process.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call